The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study

W. P. Steward, M. Middleton, A. Benghiat, P. M. Loadman, C. Hayward, S. Waller, S. Ford, G. Halbert, L. H. Patterson, D. Talbot

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study'. Together they form a unique fingerprint.

Medicine & Life Sciences